Application 021137
- Type
- NDA
- Sponsor
- GENUS LIFESCIENCES
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LEVOLET | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.025MG | No | No |
| 002 | LEVOLET | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.05MG | No | No |
| 003 | LEVOLET | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.075MG | No | No |
| 004 | LEVOLET | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.088MG | No | No |
| 005 | LEVOLET | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.1MG | No | No |
| 006 | LEVOLET | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.112MG | No | No |
| 007 | LEVOLET | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.125MG | No | No |
| 008 | LEVOLET | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.137MG | No | No |
| 009 | LEVOLET | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.15MG | No | No |
| 010 | LEVOLET | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.175MG | No | No |
| 011 | LEVOLET | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.2MG | No | No |
| 012 | LEVOLET | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.3MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021137-001 | LEVOLET | LEVOTHYROXINE SODIUM | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | |
| N021137-002 | LEVOLET | LEVOTHYROXINE SODIUM | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | |
| N021137-003 | LEVOLET | LEVOTHYROXINE SODIUM | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | |
| N021137-004 | LEVOLET | LEVOTHYROXINE SODIUM | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | |
| N021137-005 | LEVOLET | LEVOTHYROXINE SODIUM | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | |
| N021137-006 | LEVOLET | LEVOTHYROXINE SODIUM | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | |
| N021137-007 | LEVOLET | LEVOTHYROXINE SODIUM | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | |
| N021137-008 | LEVOLET | LEVOTHYROXINE SODIUM | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | |
| N021137-009 | LEVOLET | LEVOTHYROXINE SODIUM | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | |
| N021137-010 | LEVOLET | LEVOTHYROXINE SODIUM | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | |
| N021137-011 | LEVOLET | LEVOTHYROXINE SODIUM | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | |
| N021137-012 | LEVOLET | LEVOTHYROXINE SODIUM | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N021137-001 | AB1 |
| N021137-001 | AB2 |
| N021137-001 | AB3 |
| N021137-001 | AB4 |
| N021137-002 | AB1 |
| N021137-002 | AB2 |
| N021137-002 | AB3 |
| N021137-002 | AB4 |
| N021137-003 | AB1 |
| N021137-003 | AB2 |
| N021137-003 | AB3 |
| N021137-003 | AB4 |
| N021137-004 | AB1 |
| N021137-004 | AB2 |
| N021137-004 | AB3 |
| N021137-004 | AB4 |
| N021137-005 | AB1 |
| N021137-005 | AB2 |
| N021137-005 | AB3 |
| N021137-005 | AB4 |
| N021137-006 | AB1 |
| N021137-006 | AB2 |
| N021137-006 | AB3 |
| N021137-006 | AB4 |
| N021137-007 | AB1 |
| N021137-007 | AB2 |
| N021137-007 | AB3 |
| N021137-007 | AB4 |
| N021137-008 | AB1 |
| N021137-008 | AB2 |
| N021137-008 | AB3 |
| N021137-008 | AB4 |
| N021137-009 | AB1 |
| N021137-009 | AB2 |
| N021137-009 | AB3 |
| N021137-009 | AB4 |
| N021137-010 | AB1 |
| N021137-010 | AB2 |
| N021137-010 | AB3 |
| N021137-010 | AB4 |
| N021137-011 | AB1 |
| N021137-011 | AB2 |
| N021137-011 | AB3 |
| N021137-011 | AB4 |
| N021137-012 | AB1 |
| N021137-012 | AB2 |
| N021137-012 | AB3 |
| N021137-012 | AB4 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N021137-003 | 10231931 | 2038-03-23 | Drug product | 2022-01-07 | |
| N021137-003 | 10406108 | 2038-03-23 | Drug product | 2022-01-07 | |
| N021137-004 | 10231931 | 2038-03-23 | Drug product | 2022-01-07 | |
| N021137-004 | 10406108 | 2038-03-23 | Drug product | 2022-01-07 | |
| N021137-005 | 10231931 | 2038-03-23 | Drug product | 2022-01-07 | |
| N021137-005 | 10406108 | 2038-03-23 | Drug product | 2022-01-07 | |
| N021137-006 | 10231931 | 2038-03-23 | Drug product | 2022-01-07 | |
| N021137-006 | 10406108 | 2038-03-23 | Drug product | 2022-01-07 | |
| N021137-007 | 10231931 | 2038-03-23 | Drug product | 2022-01-07 | |
| N021137-007 | 10406108 | 2038-03-23 | Drug product | 2022-01-07 | |
| N021137-008 | 10231931 | 2038-03-23 | Drug product | 2022-01-07 | |
| N021137-008 | 10406108 | 2038-03-23 | Drug product | 2022-01-07 | |
| N021137-009 | 10231931 | 2038-03-23 | Drug product | 2022-01-07 | |
| N021137-009 | 10406108 | 2038-03-23 | Drug product | 2022-01-07 | |
| N021137-010 | 10231931 | 2038-03-23 | Drug product | 2022-01-07 | |
| N021137-010 | 10406108 | 2038-03-23 | Drug product | 2022-01-07 | |
| N021137-011 | 10231931 | 2038-03-23 | Drug product | 2022-01-07 | |
| N021137-011 | 10406108 | 2038-03-23 | Drug product | 2022-01-07 | |
| N021137-012 | 10231931 | 2038-03-23 | Drug product | 2022-01-07 | |
| N021137-012 | 10406108 | 2038-03-23 | Drug product | 2022-01-07 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2024-10-29 15:01 UTC | 2024-10 | N021137-005 | LEVOLET | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N021137-006 | LEVOLET | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N021137-007 | LEVOLET | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N021137-008 | LEVOLET | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N021137-009 | LEVOLET | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N021137-010 | LEVOLET | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N021137-011 | LEVOLET | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N021137-012 | LEVOLET | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021137-001 | LEVOLET | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021137-002 | LEVOLET | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021137-003 | LEVOLET | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021137-004 | LEVOLET | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021137-005 | LEVOLET | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021137-006 | LEVOLET | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021137-007 | LEVOLET | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021137-008 | LEVOLET | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021137-009 | LEVOLET | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021137-010 | LEVOLET | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021137-011 | LEVOLET | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021137-012 | LEVOLET | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021137-001 | LEVOLET | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021137-002 | LEVOLET | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021137-003 | LEVOLET | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021137-004 | LEVOLET | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021137-005 | LEVOLET | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021137-006 | LEVOLET | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021137-007 | LEVOLET | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021137-008 | LEVOLET | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021137-009 | LEVOLET | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021137-010 | LEVOLET | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021137-011 | LEVOLET | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021137-012 | LEVOLET | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021137-001 | LEVOLET | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021137-002 | LEVOLET | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021137-003 | LEVOLET | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021137-004 | LEVOLET | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021137-005 | LEVOLET | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021137-006 | LEVOLET | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021137-007 | LEVOLET | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021137-008 | LEVOLET | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2003-06-06 | 1e350fbaab3a… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N021137-001 | AB1 | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N021137-001 | AB2 | 2 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N021137-001 | AB3 | 3 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N021137-001 | AB4 | 4 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N021137-002 | AB1 | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N021137-002 | AB2 | 2 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N021137-002 | AB3 | 3 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N021137-002 | AB4 | 4 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N021137-003 | AB1 | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N021137-003 | AB2 | 2 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N021137-003 | AB3 | 3 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N021137-003 | AB4 | 4 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N021137-004 | AB1 | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N021137-004 | AB2 | 2 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N021137-004 | AB3 | 3 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N021137-004 | AB4 | 4 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N021137-005 | AB1 | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N021137-005 | AB2 | 2 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N021137-005 | AB3 | 3 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N021137-005 | AB4 | 4 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N021137-006 | AB1 | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N021137-006 | AB2 | 2 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N021137-006 | AB3 | 3 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N021137-006 | AB4 | 4 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N021137-007 | AB1 | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N021137-007 | AB2 | 2 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N021137-007 | AB3 | 3 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N021137-007 | AB4 | 4 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N021137-008 | AB1 | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N021137-008 | AB2 | 2 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N021137-008 | AB3 | 3 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N021137-008 | AB4 | 4 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N021137-009 | AB1 | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N021137-009 | AB2 | 2 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N021137-009 | AB3 | 3 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N021137-009 | AB4 | 4 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N021137-010 | AB1 | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N021137-010 | AB2 | 2 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N021137-010 | AB3 | 3 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N021137-010 | AB4 | 4 | d4dbc9d85df4… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N021137-003 | 10231931 | 2038-03-23 | Drug product | 2022-01-07 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N021137-003 | 10406108 | 2038-03-23 | Drug product | 2022-01-07 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N021137-004 | 10231931 | 2038-03-23 | Drug product | 2022-01-07 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N021137-004 | 10406108 | 2038-03-23 | Drug product | 2022-01-07 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N021137-005 | 10231931 | 2038-03-23 | Drug product | 2022-01-07 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N021137-005 | 10406108 | 2038-03-23 | Drug product | 2022-01-07 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N021137-006 | 10231931 | 2038-03-23 | Drug product | 2022-01-07 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N021137-006 | 10406108 | 2038-03-23 | Drug product | 2022-01-07 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N021137-007 | 10231931 | 2038-03-23 | Drug product | 2022-01-07 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N021137-007 | 10406108 | 2038-03-23 | Drug product | 2022-01-07 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N021137-008 | 10231931 | 2038-03-23 | Drug product | 2022-01-07 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N021137-008 | 10406108 | 2038-03-23 | Drug product | 2022-01-07 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N021137-009 | 10231931 | 2038-03-23 | Drug product | 2022-01-07 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N021137-009 | 10406108 | 2038-03-23 | Drug product | 2022-01-07 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N021137-010 | 10231931 | 2038-03-23 | Drug product | 2022-01-07 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N021137-010 | 10406108 | 2038-03-23 | Drug product | 2022-01-07 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N021137-011 | 10231931 | 2038-03-23 | Drug product | 2022-01-07 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N021137-011 | 10406108 | 2038-03-23 | Drug product | 2022-01-07 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N021137-012 | 10231931 | 2038-03-23 | Drug product | 2022-01-07 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N021137-012 | 10406108 | 2038-03-23 | Drug product | 2022-01-07 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | N021137-003 | 10231931 | 2038-03-23 | Drug product | 2022-01-07 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N021137-003 | 10406108 | 2038-03-23 | Drug product | 2022-01-07 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N021137-004 | 10231931 | 2038-03-23 | Drug product | 2022-01-07 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N021137-004 | 10406108 | 2038-03-23 | Drug product | 2022-01-07 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N021137-005 | 10231931 | 2038-03-23 | Drug product | 2022-01-07 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N021137-005 | 10406108 | 2038-03-23 | Drug product | 2022-01-07 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N021137-006 | 10231931 | 2038-03-23 | Drug product | 2022-01-07 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N021137-006 | 10406108 | 2038-03-23 | Drug product | 2022-01-07 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N021137-007 | 10231931 | 2038-03-23 | Drug product | 2022-01-07 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N021137-007 | 10406108 | 2038-03-23 | Drug product | 2022-01-07 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N021137-008 | 10231931 | 2038-03-23 | Drug product | 2022-01-07 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N021137-008 | 10406108 | 2038-03-23 | Drug product | 2022-01-07 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N021137-009 | 10231931 | 2038-03-23 | Drug product | 2022-01-07 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N021137-009 | 10406108 | 2038-03-23 | Drug product | 2022-01-07 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N021137-010 | 10231931 | 2038-03-23 | Drug product | 2022-01-07 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N021137-010 | 10406108 | 2038-03-23 | Drug product | 2022-01-07 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N021137-011 | 10231931 | 2038-03-23 | Drug product | 2022-01-07 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N021137-011 | 10406108 | 2038-03-23 | Drug product | 2022-01-07 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N021137-012 | 10231931 | 2038-03-23 | Drug product | 2022-01-07 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N021137-012 | 10406108 | 2038-03-23 | Drug product | 2022-01-07 | c2088c7a36db… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 8849620a-5e8d-4031-884f-9a2817b050f2 | 2026-11-09 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| LEVOXYL | LEVOTHYROXINE SODIUM | Pfizer Laboratories Div Pfizer Inc | 758588c3-c63e-491b-0aa2-4f50d80cb174 | 2026-11-06 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | fc803107-aaa2-4753-ab97-7b4ed5cf4be5 | 2026-11-05 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 3b282e57-1009-4d2c-8ca2-9cca9f791937 | 2026-11-05 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | d35b5250-c26d-4d67-8a33-2f993b13e3e9 | 2026-11-05 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 48c29432-a36c-4787-a05f-8d25a0abcc37 | 2026-11-04 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | c1b0fbad-5816-4152-ab59-05079e8c2148 | 2026-11-02 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 3e77de84-6f59-40ac-a1a4-7bfe30387823 | 2026-10-27 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | REMEDYREPACK INC. | 0fa2e2f5-401b-45c1-b6a5-d02f6faf509d | 2026-10-27 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | c22af2e0-fb36-4645-a911-3d293af5bd88 | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | d79526e0-d327-4545-a50c-99678766d817 | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | NuCare Pharmaceuticals,Inc. | 5da80d6d-4895-ad6c-e063-6394a90ae6f5 | 2026-10-12 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | NuCare Pharmaceuticals,Inc. | 5da82b4e-bf84-c482-e063-6394a90addf9 | 2026-10-12 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 8bc641d8-0185-49b2-9c1f-d886bf5ce098 | 2026-10-07 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 1a2124e6-aea2-40dd-bb8d-52c58405a67e | 2026-10-01 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 48a366d8-f5ac-47b0-84e3-f88251def70c | 2026-09-28 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 01d2c8c9-db54-4002-8f79-4ec396531024 | 2026-09-18 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 255ad500-6656-4cd0-b4d1-10cc22f9e61b | 2026-09-18 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | cee5ca2e-4780-4c54-a895-0f9fb2986c1e | 2026-09-18 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Cardinal Health 107, LLC | 31a31756-68aa-4e01-bbb1-9d181f8d9181 | 2026-09-18 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.